X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1391) 1391
Publication (147) 147
Book Review (16) 16
Book Chapter (4) 4
Conference Proceeding (2) 2
Dissertation (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1153) 1153
index medicus (814) 814
female (661) 661
thrombotic microangiopathy (598) 598
male (558) 558
adult (501) 501
hematology (488) 488
thrombotic thrombocytopenic purpura (478) 478
transplantation (414) 414
middle aged (383) 383
hemolytic-uremic syndrome (374) 374
immunology (371) 371
thrombocytopenic purpura (271) 271
factor-cleaving protease (232) 232
adamts13 protein (223) 223
von-willebrand-factor (195) 195
aged (179) 179
treatment outcome (175) 175
adolescent (172) 172
plasma exchange (166) 166
diagnosis (162) 162
risk factors (162) 162
urology & nephrology (159) 159
child (158) 158
oncology (154) 154
animals (152) 152
antibodies (147) 147
retrospective studies (141) 141
adamts13 (139) 139
purpura, thrombotic thrombocytopenic - therapy (139) 139
surgery (139) 139
purpura, thrombotic thrombocytopenic - diagnosis (129) 129
plasma-exchange (128) 128
young adult (127) 127
complement (124) 124
thrombotic microangiopathies - etiology (124) 124
von willebrand factor (123) 123
purpura, thrombotic thrombocytopenic - immunology (119) 119
disease (117) 117
hemolytic uremic syndrome (117) 117
analysis (116) 116
health aspects (115) 115
kidney transplantation (114) 114
immunosuppressive agents - therapeutic use (113) 113
rituximab (113) 113
adam proteins - immunology (112) 112
care and treatment (110) 110
rheumatology (109) 109
biopsy (106) 106
peripheral vascular disease (105) 105
recurrence (105) 105
thrombosis (105) 105
kidneys (104) 104
autoantibodies (103) 103
autoantibodies - blood (100) 100
eculizumab (100) 100
medicine & public health (100) 100
purpura, thrombotic thrombocytopenic - blood (99) 99
hematopoietic stem cells (97) 97
pediatrics (94) 94
child, preschool (93) 93
medicine, general & internal (93) 93
prognosis (93) 93
bone-marrow-transplantation (91) 91
microangiopathy (88) 88
microangiopathies (87) 87
mutation (87) 87
hemic and lymphatic diseases (86) 86
stem cells (85) 85
hematopoietic stem cell transplantation - adverse effects (83) 83
antibodies, monoclonal, humanized - therapeutic use (82) 82
antiphospholipid syndrome (82) 82
kidney - pathology (82) 82
versus-host-disease (82) 82
pregnancy (80) 80
patients (79) 79
anemia (78) 78
mutations (77) 77
purpura, thrombotic thrombocytopenic - etiology (77) 77
article (76) 76
diagnosis, differential (76) 76
plasma (76) 76
therapy (76) 76
adam proteins - blood (75) 75
systemic-lupus-erythematosus (75) 75
ttp (75) 75
von willebrand factor - metabolism (75) 75
atypical hemolytic uremic syndrome (74) 74
complement activation (74) 74
thrombocytopenia (74) 74
children (73) 73
purpura (73) 73
thrombotic microangiopathies - diagnosis (73) 73
hypertension (72) 72
plasmapheresis (70) 70
transplantation, homologous (69) 69
hemolytic-uremic syndrome - immunology (68) 68
thrombotic microangiopathies - immunology (68) 68
time factors (67) 67
infant (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1367) 1367
French (8) 8
Japanese (6) 6
German (4) 4
Spanish (3) 3
Chinese (1) 1
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 06/2017, Volume 91, Issue 6, pp. 1420 - 1425
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 4, pp. 518 - 525
Abstract We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Hematopoietic stem cell transplant | Eculizumab | Thrombotic microangiopathy | Eculizumab pharmacokinetics | CH50 | DIAGNOSIS | LONG-TERM SURVIVORS | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | IMMUNOLOGY | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | Hematopoietic stem cell | CYSTATIN-C | transplant | Eculizumab pharrnacokinetics | CHRONIC KIDNEY-DISEASE | HYPERTENSION | HEMATOLOGY | CHSO | Hematologic Neoplasms - therapy | Severity of Illness Index | Complement Hemolytic Activity Assay | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Child, Preschool | Complement Membrane Attack Complex - antagonists & inhibitors | Thrombotic Microangiopathies - mortality | Transplantation, Autologous | Hematologic Neoplasms - pathology | Transplantation, Homologous | Drug Dosage Calculations | Complement Inactivating Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Hematologic Neoplasms - immunology | Thrombotic Microangiopathies - etiology | Drug Monitoring | Child | Thrombotic Microangiopathies - immunology | Thrombotic Microangiopathies - drug therapy | Hypertension | Enzymes | Mortality | Stem cells | Transplantation | Children | Health aspects | Hematopoietic stem cells
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 06/2014, Volume 40, Issue 4, pp. 444 - 464
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 9, pp. 1580 - 1582
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 09/2015, Volume 41, Issue 6, pp. 556 - 562
Abstract Thrombotic microangiopathy (TMA) is characterized by the presence of microangiopathic hemolytic anemia and thrombocytopenia. There are several... 
ADAMTS-13 | endothelium | microangiopathic hemolytic anemia | thrombocytopenia | thrombotic thrombocytopenic purpura | thrombotic microangiopathy | complement | neutrophils | hemolytic uremic syndrome | HEMOLYTIC-UREMIC SYNDROME | COMPLEMENT ACTIVATION | ADAMTS-13 DEFICIENCY | SEPSIS | VON-WILLEBRAND-FACTOR | FACTOR-CLEAVING PROTEASE | PLASMA-EXCHANGE | DISSEMINATED INTRAVASCULAR COAGULATION | THROMBOCYTOPENIC PURPURA | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | TYPE-1 REPEATS | Shock, Septic - etiology | Humans | Immunosuppressive Agents - therapeutic use | Pregnancy Complications, Hematologic - blood | Male | Thrombotic Microangiopathies - complications | Antiphospholipid Syndrome - complications | Extracellular Traps - immunology | Purpura, Thrombotic Thrombocytopenic - drug therapy | Female | Thrombotic Microangiopathies - blood | Antiphospholipid Syndrome - blood | Single-Domain Antibodies | Thrombotic Microangiopathies - immunology | Endothelium, Vascular - physiopathology | Neutrophils - immunology | ADAM Proteins - deficiency | ADAMTS13 Protein | Pregnancy | Purpura, Thrombotic Thrombocytopenic - enzymology | Disseminated Intravascular Coagulation - etiology | Multiple Organ Failure - etiology | Thrombotic Microangiopathies - therapy | ADAM Proteins - genetics | Purpura, Thrombotic Thrombocytopenic - blood | Thrombotic Microangiopathies - chemically induced | Inflammation - physiopathology
Journal Article
American Journal of Hematology, ISSN 0361-8609, 05/2015, Volume 90, Issue 5, pp. 406 - 410
Many drugs have been reported to cause thrombotic microangiopathy (TMA), often described as thrombotic thrombocytopenic purpura (TTP) or hemolytic‐uremic... 
INDUCED IMMUNE THROMBOCYTOPENIA | TTP | HEMOLYTIC-UREMIC SYNDROME | ABUSE | PURPURA | QUININE | CLINICAL-FEATURES | OUTCOMES | HEMATOLOGY | Pentostatin - adverse effects | Pentostatin - administration & dosage | Humans | Oklahoma | Hemolytic-Uremic Syndrome - blood | Organoplatinum Compounds - administration & dosage | Quinine - adverse effects | Hemolytic-Uremic Syndrome - physiopathology | Deoxycytidine - adverse effects | Registries | Thrombotic Microangiopathies - blood | Purpura, Thrombotic Thrombocytopenic - physiopathology | Thrombotic Microangiopathies - immunology | Wisconsin | Vancomycin - administration & dosage | Ambulatory Care Facilities - statistics & numerical data | Hemolytic-Uremic Syndrome - chemically induced | Thrombotic Microangiopathies - physiopathology | Deoxycytidine - administration & dosage | Hemolytic-Uremic Syndrome - immunology | Purpura, Thrombotic Thrombocytopenic - chemically induced | Vancomycin - adverse effects | Purpura, Thrombotic Thrombocytopenic - immunology | Antibodies - blood | Quinine - administration & dosage | Purpura, Thrombotic Thrombocytopenic - blood | Thrombotic Microangiopathies - chemically induced | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Drugs | Biological products | Von Willebrand factor | thrombotic thrombocytopenic purpura | drug-induced | thrombotic microangiopathy | hemolytic-uremic syndrome | quinine
Journal Article
Journal Article
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2013, Volume 24, Issue 6, pp. 496 - 502
Journal Article
Kidney International, ISSN 0085-2538, 02/2018, Volume 93, Issue 2, pp. 450 - 459
Pregnancy-associated atypical hemolytic uremic syndrome (aHUS) refers to the thrombotic microangiopathy resulting from uncontrolled complement activation... 
postpartum | cesarean section | eculizumab | complement | hemolytic uremic syndrome | GENE-MUTATIONS | SYSTEM | ACTIVATION | COMPLEMENT INHIBITOR ECULIZUMAB | PREECLAMPSIA | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | THROMBOTIC MICROANGIOPATHY | UROLOGY & NEPHROLOGY | OUTCOMES | AHUS | Complement Activation | Humans | Immunosuppressive Agents - therapeutic use | Complement C3b Inactivator Proteins - genetics | Atypical Hemolytic Uremic Syndrome - immunology | Postpartum Period | Plasma Exchange | Thrombotic Microangiopathies - epidemiology | Thrombotic Microangiopathies - genetics | Adult | Female | Registries | Retrospective Studies | Atypical Hemolytic Uremic Syndrome - genetics | Parity | Thrombotic Microangiopathies - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Atypical Hemolytic Uremic Syndrome - therapy | Risk Factors | Atypical Hemolytic Uremic Syndrome - epidemiology | Treatment Outcome | Gene Conversion | Pregnancy | Cesarean Section | Spain - epidemiology | Pregnancy Complications - genetics | Thrombotic Microangiopathies - therapy | Mutation | Complement Factor H - genetics | Pregnancy Complications - epidemiology | Pregnancy Complications - immunology | Pregnancy Complications - therapy | Renal Dialysis | Thrombotic microangiopathy | Complement activation | Hemolytic uremic syndrome | Hemodialysis | Pregnancy complications | Gene conversion | Patients | Cesarean section | Postpartum
Journal Article